Real-World Experience of Athletes Treated With SAM

Brief summary (from the registry)

Low-intensity continuous ultrasound (LICUS) is an FDA-approved bio regenerative technology, applied with a wearable device (SAM, Zetroz Systems LLC) for daily use. The treatment provides long-duration ultrasound for approximately four hours. This report included a retrospective convenience sample of 6 athletes from one sports medicine and rehabilitation facility. The objective of this report is to examine the real-world outcome data on symptoms improvement and return to function using Sam. It was hypothesized that LICUS stimulation, in conjunction with traditional therapies, will accelerate the healing process of musculoskeletal tissue leading to a reduction in pain, increase functionality, and a higher probability of returning to work and sports-related activities. The sample included athletes with sports-related musculoskeletal injuries. Demographics, injury history, treatment history, and clinical outcomes data were retrospectively collected for athletes who were treated with SAM in conjunction with traditional therapies. Clinical results showed a benefit from the treatment with a decrease in pain (100%), and 3 out of 6 athletes were able to return to work or sports (50%). Overall the study shows that Sam accelerates the healing of soft tissue leading to a decrease in both acute and chronic pain.

Study details

Official title

Efficacy of SAM Sport as an Addon to Traditional Therapy in Treating Sports-related Injuries

Conditions

• Pain, Chronic
• Pain, Acute
• Sport Injury
• Soft Tissue Injuries
• Arm Injury
• Back Pain
• Tendon Injuries
• Muscle Injury

Interventions

• Device: Low Intensity Continuous Ultrasound

Sponsor

ZetrOZ, Inc.

Start date

2015-10-01

Primary completion

2015-10-31

Sex

All

Age range

from 18 Years to 54 Years

Results posted

No results posted in this snapshot

Total sites listed

0

Eligibility criteria